Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
BACKGROUND: Lung cancer is known as the top cancer killer in most developed countries. However, there is currently no promising diagnostic or prognostic biomarker for lung cancer. This study aims to discover non-invasive differential markers in the serum of lung cancer patients, to determine the pro...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883701/ https://www.ncbi.nlm.nih.gov/pubmed/20502455 http://dx.doi.org/10.1038/sj.bjc.6605700 |